MBOT - Microbot Medical jumps 47% on collaboration with Stryker for neurovascular applications

Microbot Medical (NASDAQ:MBOT) soars 46.7% premarket after entering into a strategic collaboration agreement with Stryker (NYSE:SYK), a global medical technology company. The company will collaborate with Stryker’s Neurovascular division to integrate its neurovascular instruments with Microbot’s LIBERTY Robotic System to develop dedicated robotic procedural kits for use in certain neurovascular procedures. Other details are not disclosed. The company will continue to develop the LIBERTY Robotic System independently for use in peripheral and coronary procedures. Last week, MBOT secured third U.S. patent for Liberty Robotic System.

For further details see:

Microbot Medical jumps 47% on collaboration with Stryker for neurovascular applications